Cells, Free Full-Text

Immunometabolism is an emerging discipline in cancer immunotherapy. Tumor tissues are heterogeneous and influenced by metabolic reprogramming of the tumor immune microenvironment (TIME). In the TIME, multiple cell types interact, and the tumor and immune cells compete for limited nutrients, resulting in altered anticancer immunity. Therefore, metabolic reprogramming of individual cell types may influence the outcomes of immunotherapy. Understanding the metabolic competition for access to limited nutrients between tumor cells and immune cells could reveal the breadth and complexity of the TIME and aid in developing novel therapeutic approaches for cancer. In this review, we highlight that, when cells compete for nutrients, the prevailing cell type gains certain advantages over other cell types; for instance, if tumor cells prevail against immune cells for nutrients, the former gains immune resistance. Thus, a strategy is needed to selectively suppress such resistant tumor cells. Although challenging, the concept of cell type-specific metabolic pathway inhibition is a potent new strategy in anticancer immunotherapy.

Cells, Free Full-Text

Iec/Ts 62886 Get File - Colaboratory

Full-spectrum cell-free RAN for 6G systems: s

Remote immune processes revealed by immune-derived circulating cell-free DNA

Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation

JTurkGerGynecolAssoc on X: Effects of stem cells and amniotic fluid on uterus and ovaries in a rat model of abdominal adhesions: a controlled study You can see the free full text of

Labile coat: reason for noninfectious cell-free varicella-zoster virus in culture. - Abstract - Europe PMC

Oreilly Essential System Administration 3Rd Edition Aug 2002 Rar - Colaboratory

Cell-Free Protein Synthesis: Methods and Protocols

Nt Novo Cella Get File - Colaboratory

Cell-free synthesis of human interferon. - Abstract - Europe PMC